Platelet function and filamin A expression in two families with novel FLNA gene mutations associated with periventricular nodular heterotopia and panlobular emphysema

Am J Med Genet A. 2022 Jun;188(6):1716-1722. doi: 10.1002/ajmg.a.62690. Epub 2022 Feb 14.

Abstract

Pathogenic variants of the X-linked FLNA gene encoding filamin A protein have been associated with a wide spectrum of symptoms, including the recently described pulmonary phenotype with childhood-onset panlobular emphysema. We describe three female patients from two families with novel heterozygous FLNA variants c.5837_2del and c.508C > T. Analysis of immunofluorescence of peripheral blood smears and platelet function was performed for all patients. FLNA-negative platelets were observed, suggesting that these variants result in the loss of a functional protein product. All three patients also had periventricular nodular heterotopia and panlobular emphysema. However, they had considerably milder symptoms and later age of onset than in the previously reported cases. Therefore, patients with pathogenic FLNA variants should be studied actively for lung involvement even in the absence of pronounced respiratory symptoms. Conversely, any patient with unexplained panlobular emphysema should be analyzed for pathogenic FLNA variants. We also suggest that immunofluorescence analysis is a useful tool for investigating the pathogenicity of novel FLNA variants.

Keywords: filamin A; panlobular emphysema; periventricular nodular heterotopia; platelet function test; thrombocytopenia.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Female
  • Filamins / genetics
  • Humans
  • Mutation
  • Periventricular Nodular Heterotopia* / diagnosis
  • Periventricular Nodular Heterotopia* / genetics
  • Phenotype
  • Pulmonary Emphysema*

Substances

  • FLNA protein, human
  • Filamins